The effect of polycarbophil gel (Replens™) on bacterial vaginosis: A pilot study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 130, Issue 1, 2007, Pages 132-136

  Wu, Justine P ^a   Fielding, Stephen L ^b   Fiscella, Kevin ^c  

^a Highland Hospital Rochester   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Bacterial vaginosis; Polycarbophil gel; Replens

Indexed keywords

MIPHIL; POLYCARBOPHIL; REPLENS;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; PH; PILOT STUDY; PRIORITY JOURNAL; VAGINA DISCHARGE; VAGINAL LAVAGE; VAGINITIS;

EID: 33845485055     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.007     Document Type: Article

References (15)

1. Sobel J.D. Bacterial vaginosis. Ann Rev Med 51 (2000) 349-356
2. Cook R.L., Redondo-Lopez V., Schmitt C., Meriwether C., and Sobel J.D. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 30 4 (1992) 870-877
3. Koumans E.H., and Kendrick J.S. Preventing adverse sequelae of bacterial vaginosis: public health program and research agenda. CDC Bacterial Vaginosis Working Group. Sex Transm Dis 28 (2001) 292-297
4. Joesoef M.R., Schmid G.P., and Hillier S.L. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 28 Suppl 1 (1999) S57-S65
5. Centers for Disease Control, Prevention. Guidelines for treatment of sexually transmitted diseases. Morb Mortal Wkly Rep 47 (1998) 70-74
6. Nachtigall L.E. Comparative study: Replens™ versus local estrogen in menopausal women. Fertil Steril 61 (1994) 178-180
7. Milani M., and Molteni B. Effects of miphil, a new polycarbophil vaginal gel, in suspected bacterial vaginosis: a randomized study versus vaginal douche. Obstet Gynecol 95 (2000) S58
8. Paernoster D.M., Tudor L., Milani M., Maggino T., and Ambrosini A. Efficacy of an acidic vaginal gel on vaginal pH and inaterleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial. J Mater Fet Neonat Med 15 (2004) 198-201
9. Fiorilli A., Molteni B., and Milani M. Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised, double-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 120 (2005) 202-205
10. Schwebke J.R., Hillier S.L., Sobel J.D., McGregor J.A., and Sweet R.L. Validity of the vaginal Gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 88 (1996) 573-576
11. Boggess K.A., et al. Use of DNA hybridization to detect vaginal pathogens associated with bacterial vaginosis among asymptomatic pregnant women. Am J Obstet Gynecol 193 (2005) 752-756
12. Fredricks D.N., Fiedler T.L., and Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353 (2005) 1899-1911
13. Pereira L., Culhane J., McCollum K.I., Agnew K., and Nyirjesy P. Variation in microbiologic profiles among pregnant women with bacterial vaginosis. Am J Obstet Gynecol 193 (2005) 746-751
14. Brown J., Hooper G., Kenyon C.J., et al. Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm Res 14 (1997) 1073-1078
15. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 80 (2004) 8-11